𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins)

✍ Scribed by M. Igel; T. Sudhop; K. von Bergmann

Publisher
Springer
Year
2001
Tongue
English
Weight
101 KB
Volume
57
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of 3-hydroxy-3-methylglutaryl
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase
✍ Gene C. Ness 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 634 KB

Within the last few years considerable evidence has accumulated which indicates that changes in HMG-CoA reductase are due primarily, if not solely, to changes in enzyme quantity. These include the changes caused by insulin, glucagon, cholesterol, mevalonolactone, cholestyramine, compactin, cyclic mo

Statins, inhibitors of 3-hydroxy-3-methy
Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production
✍ Hideki Amuro; Tomoki Ito; Rie Miyamoto; Hiroyuki Sugimoto; Yoshitaro Torii; Yons 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

## Abstract ## Objective Statins, which are used as cholesterol‐lowering agents, have pleiotropic immunomodulatory properties. Although beneficial effects of statins have been reported in autoimmune diseases, the mechanisms of these immunomodulatory effects are still poorly understood. Type I inte

Synthesis and stability of a carbon-14-l
Synthesis and stability of a carbon-14-labeled 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor
✍ Richard C. Burrell; Samuel J. Bonacorsi Jr.; J. Kent Rinehart; Saleem Ahmad; Khe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 176 KB

## Abstract Inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme‐A reductase (HMGR) is an effective method of lowering plasma low‐density lipoprotein cholesterol levels. Hemi‐calcium (3R,5S,E)‐7‐(4‐(4‐fluorophenyl)‐6‐isopropyl‐2‐(methyl(1‐methyl‐1H‐1,2,4‐triazol‐5‐yl)amino)pyrimidin‐5‐yl)‐3,5‐dihydrox